tiprankstipranks
Can-Fite BioPharma (CANF)
:CANF
US Market

Can-Fite BioPharma (CANF) Technical Analysis

Compare
557 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Can-Fite BioPharma’s (CANF) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Can-Fite BioPharma is a Sell.
Can-Fite BioPharma’s (CANF) 20-Day exponential moving average is 1.65, while Can-Fite BioPharma’s (CANF) share price is $1.76, making it a Buy.
Can-Fite BioPharma’s (CANF) 50-Day exponential moving average is 1.66, while Can-Fite BioPharma’s (CANF) share price is $1.76, making it a Buy.

Can-Fite BioPharma (CANF) Pivot Points

Mar 04, 2025, 06:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.66
1.69
1.73
1.76
1.80
1.83
1.87
Fibonacci
1.69
1.72
1.74
1.76
1.79
1.81
1.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Can-Fite BioPharma (CANF) Moving Averages

Mar 04, 2025, 06:57 AM
Period
Simple
Exponential
MA5
1.76Buy
1.75Buy
MA10
1.72Buy
1.71Buy
MA20
1.58Buy
1.65Buy
MA50
1.57Buy
1.66Buy
MA100
1.86Sell
1.80Sell
MA200
2.24Sell
2.07Sell
Can-Fite BioPharma’s (CANF) 10-Day exponential moving average is 1.71, while Can-Fite BioPharma’s (CANF) share price is $1.76, making it a Buy.
Can-Fite BioPharma’s (CANF) 100-Day exponential moving average is 1.80, while Can-Fite BioPharma’s (CANF) share price is $1.76, making it a Sell.
Can-Fite BioPharma’s (CANF) stock price is $1.76 and Can-Fite BioPharma’s (CANF) 50-day simple moving average is 1.57, creating a Buy signal.
Can-Fite BioPharma’s (CANF) stock price is $1.76 and Can-Fite BioPharma’s (CANF) 100-day simple moving average is 1.86, creating a Sell signal.
Can-Fite BioPharma’s (CANF) stock price is $1.76 and Can-Fite BioPharma’s (CANF) 200-day simple moving average is 2.24, creating a Sell signal.

Can-Fite BioPharma (CANF) Technical Indicators

Mar 04, 2025, 06:57 AM
Name
Value
Implied Action
RSI (14)
60.38
Neutral
STOCH (9,6)
49.90
Neutral
STOCHRSI (14)
59.02
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
29.25
Neutral
Williams %R
-41.79
Buy
CCI (14)
93.64
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
51.93
Neutral
ROC
28.47
Buy
Can-Fite BioPharma’s (CANF) Relative Strength Index (RSI) is 60.38, creating a Neutral signal.
Can-Fite BioPharma’s (CANF) Trend Strength Indicator (ADX) is 29.25, creating a Neutral signal.
Can-Fite BioPharma’s (CANF) Commodity Channel Index (CCI) is 93.64, creating a Neutral signal.
Can-Fite BioPharma’s (CANF) Price Rate of Change (ROC) is 28.47, creating a Buy signal.

FAQ

Is CANF a Buy, Hold, or Sell?
Based on CANF’s technical indicators, CANF is a Buy.
    What is CANF’s RSI (14)?
    CANF’s RSI (14) is 60.38, which suggests CANF is a Neutral.
      What is CANF’s MACD?
      CANF’s MACD is 0.06, which suggests CANF is a Sell.
        What is CANF’s 5-day moving average?
        CANF’s 5-day moving average is 1.76, which suggests CANF is a Buy.
          What is CANF’s 20-day moving average?
          CANF 20-day moving average is 1.58, which suggests CANF is a Buy.
            What is CANF’s 50-day moving average?
            CANF’s 50-day moving average is 1.57, which suggests CANF is a Buy.
              What is CANF’s 200-day moving average?
              CANF’s 200-day moving average is 2.24, which suggests CANF is a Sell.
                What is CANF’s Williams % R (14)?
                CANF’s Williams % R (14) is -41.79, which suggests CANF is a Buy.
                  What is CANF’s CCI (14)?
                  CANF’s CCI (14) is 93.64, which suggests CANF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis